

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 6.79446281 |
| 2 | muscle filament sliding (GO:0030049) | 6.79446281 |
| 3 | actin-mediated cell contraction (GO:0070252) | 5.80557697 |
| 4 | fatty acid beta-oxidation (GO:0006635) | 5.28958416 |
| 5 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.27964999 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 5.25721122 |
| 7 | fatty acid transmembrane transport (GO:1902001) | 5.21305140 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.16905687 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 5.16905687 |
| 10 | carnitine shuttle (GO:0006853) | 5.16747317 |
| 11 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.14390384 |
| 12 | lysine catabolic process (GO:0006554) | 5.13429752 |
| 13 | lysine metabolic process (GO:0006553) | 5.13429752 |
| 14 | regulation of relaxation of muscle (GO:1901077) | 5.11836810 |
| 15 | sarcomere organization (GO:0045214) | 4.96020124 |
| 16 | L-phenylalanine metabolic process (GO:0006558) | 4.95068281 |
| 17 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.95068281 |
| 18 | regulation of sequestering of triglyceride (GO:0010889) | 4.93481986 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.82872749 |
| 20 | myofibril assembly (GO:0030239) | 4.82827352 |
| 21 | fatty acid oxidation (GO:0019395) | 4.78795026 |
| 22 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.75675780 |
| 23 | lipid oxidation (GO:0034440) | 4.72394414 |
| 24 | fatty acid catabolic process (GO:0009062) | 4.72285636 |
| 25 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.67328888 |
| 26 | regulation of triglyceride catabolic process (GO:0010896) | 4.66014179 |
| 27 | cardiac myofibril assembly (GO:0055003) | 4.65520534 |
| 28 | creatine metabolic process (GO:0006600) | 4.65025762 |
| 29 | tricarboxylic acid cycle (GO:0006099) | 4.58174237 |
| 30 | acetyl-CoA metabolic process (GO:0006084) | 4.55989720 |
| 31 | glyoxylate metabolic process (GO:0046487) | 4.51750847 |
| 32 | 2-oxoglutarate metabolic process (GO:0006103) | 4.51020962 |
| 33 | amino-acid betaine metabolic process (GO:0006577) | 4.50532478 |
| 34 | short-chain fatty acid metabolic process (GO:0046459) | 4.50488930 |
| 35 | actin filament-based movement (GO:0030048) | 4.44593417 |
| 36 | aromatic amino acid family catabolic process (GO:0009074) | 4.40007576 |
| 37 | branched-chain amino acid catabolic process (GO:0009083) | 4.39703571 |
| 38 | carnitine metabolic process (GO:0009437) | 4.36753902 |
| 39 | biotin metabolic process (GO:0006768) | 4.33973296 |
| 40 | cellular ketone body metabolic process (GO:0046950) | 4.33663621 |
| 41 | carnitine transmembrane transport (GO:1902603) | 4.33638375 |
| 42 | valine metabolic process (GO:0006573) | 4.32019881 |
| 43 | regulation of actin filament-based movement (GO:1903115) | 4.31011974 |
| 44 | aspartate family amino acid catabolic process (GO:0009068) | 4.29470138 |
| 45 | monocarboxylic acid catabolic process (GO:0072329) | 4.29071265 |
| 46 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.26670141 |
| 47 | regulation of skeletal muscle contraction (GO:0014819) | 4.24887360 |
| 48 | oxaloacetate metabolic process (GO:0006107) | 4.22511328 |
| 49 | amino-acid betaine transport (GO:0015838) | 4.19823572 |
| 50 | carnitine transport (GO:0015879) | 4.19823572 |
| 51 | cardiac muscle contraction (GO:0060048) | 4.19129787 |
| 52 | glycogen catabolic process (GO:0005980) | 4.18380889 |
| 53 | positive regulation of fatty acid oxidation (GO:0046321) | 4.15865030 |
| 54 | kynurenine metabolic process (GO:0070189) | 4.13798241 |
| 55 | sulfur amino acid catabolic process (GO:0000098) | 4.13028245 |
| 56 | bile acid biosynthetic process (GO:0006699) | 4.12908686 |
| 57 | regulation of fatty acid oxidation (GO:0046320) | 4.10450269 |
| 58 | branched-chain amino acid metabolic process (GO:0009081) | 4.08641064 |
| 59 | striated muscle contraction (GO:0006941) | 4.08109702 |
| 60 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.08074625 |
| 61 | cysteine metabolic process (GO:0006534) | 4.05882178 |
| 62 | glucan catabolic process (GO:0009251) | 4.05771880 |
| 63 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.04629485 |
| 64 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.95919994 |
| 65 | skeletal muscle contraction (GO:0003009) | 3.94776480 |
| 66 | actomyosin structure organization (GO:0031032) | 3.90594163 |
| 67 | regulation of cell communication by electrical coupling (GO:0010649) | 3.87456961 |
| 68 | cellular polysaccharide catabolic process (GO:0044247) | 3.87233250 |
| 69 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.86405451 |
| 70 | regulation of cholesterol metabolic process (GO:0090181) | 3.78358938 |
| 71 | indole-containing compound catabolic process (GO:0042436) | 3.77963344 |
| 72 | indolalkylamine catabolic process (GO:0046218) | 3.77963344 |
| 73 | tryptophan catabolic process (GO:0006569) | 3.77963344 |
| 74 | ethanol oxidation (GO:0006069) | 3.75607576 |
| 75 | ketone body metabolic process (GO:1902224) | 3.75329675 |
| 76 | positive regulation of lipid catabolic process (GO:0050996) | 3.73873985 |
| 77 | thioester biosynthetic process (GO:0035384) | 3.70573465 |
| 78 | acyl-CoA biosynthetic process (GO:0071616) | 3.70573465 |
| 79 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.69967930 |
| 80 | organic acid catabolic process (GO:0016054) | 3.62704757 |
| 81 | carboxylic acid catabolic process (GO:0046395) | 3.62704757 |
| 82 | plasma lipoprotein particle clearance (GO:0034381) | 3.62647030 |
| 83 | complement activation, alternative pathway (GO:0006957) | 3.61336595 |
| 84 | alpha-amino acid catabolic process (GO:1901606) | 3.60817629 |
| 85 | succinate metabolic process (GO:0006105) | 3.60752257 |
| 86 | response to mercury ion (GO:0046689) | 3.60577213 |
| 87 | triglyceride homeostasis (GO:0070328) | 3.57153716 |
| 88 | acylglycerol homeostasis (GO:0055090) | 3.57153716 |
| 89 | high-density lipoprotein particle remodeling (GO:0034375) | 3.56940083 |
| 90 | tryptophan metabolic process (GO:0006568) | 3.55734780 |
| 91 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.55203284 |
| 92 | serine family amino acid catabolic process (GO:0009071) | 3.54922146 |
| 93 | acyl-CoA metabolic process (GO:0006637) | 3.54673720 |
| 94 | thioester metabolic process (GO:0035383) | 3.54673720 |
| 95 | tricarboxylic acid metabolic process (GO:0072350) | 3.53698648 |
| 96 | triglyceride catabolic process (GO:0019433) | 3.51673182 |
| 97 | gluconeogenesis (GO:0006094) | 3.49189911 |
| 98 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.49012079 |
| 99 | urea metabolic process (GO:0019627) | 3.48672421 |
| 100 | urea cycle (GO:0000050) | 3.48672421 |
| 101 | cellular amino acid catabolic process (GO:0009063) | 3.48338165 |
| 102 | quaternary ammonium group transport (GO:0015697) | 3.48083654 |
| 103 | bile acid metabolic process (GO:0008206) | 3.45676613 |
| 104 | homocysteine metabolic process (GO:0050667) | 3.44584178 |
| 105 | polysaccharide catabolic process (GO:0000272) | 3.44009066 |
| 106 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.41488969 |
| 107 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.40631621 |
| 108 | regulation of protein activation cascade (GO:2000257) | 3.40011475 |
| 109 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.39947243 |
| 110 | neutral lipid catabolic process (GO:0046461) | 3.39277294 |
| 111 | acylglycerol catabolic process (GO:0046464) | 3.39277294 |
| 112 | negative regulation of protein activation cascade (GO:2000258) | 3.37362704 |
| 113 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.37219390 |
| 114 | response to muscle activity (GO:0014850) | 3.35096921 |
| 115 | regulation of cholesterol esterification (GO:0010872) | 3.33121436 |
| 116 | low-density lipoprotein particle clearance (GO:0034383) | 3.32268690 |
| 117 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.32189971 |
| 118 | plasma lipoprotein particle remodeling (GO:0034369) | 3.31567090 |
| 119 | protein-lipid complex remodeling (GO:0034368) | 3.31567090 |
| 120 | macromolecular complex remodeling (GO:0034367) | 3.31567090 |
| 121 | cardiac muscle hypertrophy (GO:0003300) | 3.30827951 |
| 122 | nitrogen cycle metabolic process (GO:0071941) | 3.29762184 |
| 123 | negative regulation of lipase activity (GO:0060192) | 3.28613927 |
| 124 | coenzyme catabolic process (GO:0009109) | 3.28257159 |
| 125 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.27545673 |
| 126 | protein carboxylation (GO:0018214) | 3.27545673 |
| 127 | phospholipid homeostasis (GO:0055091) | 3.27240091 |
| 128 | hexose biosynthetic process (GO:0019319) | 3.26056860 |
| 129 | very long-chain fatty acid metabolic process (GO:0000038) | 3.25692608 |
| 130 | negative regulation of fibrinolysis (GO:0051918) | 3.23468338 |
| 131 | heart contraction (GO:0060047) | 3.23036820 |
| 132 | heart process (GO:0003015) | 3.23036820 |
| 133 | NADH metabolic process (GO:0006734) | 3.22022088 |
| 134 | regulation of complement activation (GO:0030449) | 3.21340248 |
| 135 | lipid particle organization (GO:0034389) | 3.21220244 |
| 136 | reverse cholesterol transport (GO:0043691) | 3.21173986 |
| 137 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.20439011 |
| 138 | glucan biosynthetic process (GO:0009250) | 3.19177384 |
| 139 | glycogen biosynthetic process (GO:0005978) | 3.19177384 |
| 140 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.19075130 |
| 141 | fructose metabolic process (GO:0006000) | 3.18063668 |
| 142 | muscle tissue morphogenesis (GO:0060415) | 3.14950188 |
| 143 | striated muscle hypertrophy (GO:0014897) | 3.14892307 |
| 144 | fatty acid homeostasis (GO:0055089) | 3.12855545 |
| 145 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.12515749 |
| 146 | aromatic amino acid family metabolic process (GO:0009072) | 3.11808445 |
| 147 | negative regulation of complement activation (GO:0045916) | 3.10773040 |
| 148 | muscle contraction (GO:0006936) | 3.02209879 |
| 149 | regulation of the force of heart contraction (GO:0002026) | 2.98580010 |
| 150 | monosaccharide biosynthetic process (GO:0046364) | 2.98420406 |
| 151 | epoxygenase P450 pathway (GO:0019373) | 2.96273553 |
| 152 | regulation of striated muscle contraction (GO:0006942) | 2.86133910 |
| 153 | polyketide metabolic process (GO:0030638) | 2.85915743 |
| 154 | doxorubicin metabolic process (GO:0044598) | 2.85915743 |
| 155 | daunorubicin metabolic process (GO:0044597) | 2.85915743 |
| 156 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.82681832 |
| 157 | cellular response to epinephrine stimulus (GO:0071872) | 2.81603333 |
| 158 | response to epinephrine (GO:0071871) | 2.79671092 |
| 159 | glycogen metabolic process (GO:0005977) | 2.76641030 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.80520909 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.13009407 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.15196948 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.36039522 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.97101481 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.30252257 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.28075618 |
| 8 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.93999852 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.29433822 |
| 10 | AR_21909140_ChIP-Seq_LNCAP_Human | 3.04721086 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.02201270 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.36708716 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.13069160 |
| 14 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.08430537 |
| 15 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.06340368 |
| 16 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.99753707 |
| 17 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.94926096 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.86063514 |
| 19 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.81203502 |
| 20 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.64303316 |
| 21 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.60115258 |
| 22 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.60115258 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.57168308 |
| 24 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.55010049 |
| 25 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.51164980 |
| 26 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.50174675 |
| 27 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.46897644 |
| 28 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.45130834 |
| 29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38578650 |
| 30 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.38045480 |
| 31 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.34120706 |
| 32 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.28994301 |
| 33 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.28857615 |
| 34 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.28523431 |
| 35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.27008994 |
| 36 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.25843020 |
| 37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23445543 |
| 38 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19039994 |
| 39 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.14274609 |
| 40 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.12640368 |
| 41 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.11958362 |
| 42 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.11781130 |
| 43 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11437776 |
| 44 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.09253025 |
| 45 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.08331171 |
| 46 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.07263195 |
| 47 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.07227475 |
| 48 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.07089064 |
| 49 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.06411456 |
| 50 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.06240158 |
| 51 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04434462 |
| 52 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03278487 |
| 53 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.03247554 |
| 54 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00441217 |
| 55 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.00055035 |
| 56 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.00055035 |
| 57 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.99340402 |
| 58 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97630973 |
| 59 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97377449 |
| 60 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.97228881 |
| 61 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96577585 |
| 62 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.96291076 |
| 63 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.95463107 |
| 64 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.95132234 |
| 65 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.95094714 |
| 66 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.93621721 |
| 67 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.92387267 |
| 68 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.91935148 |
| 69 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90925699 |
| 70 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90532941 |
| 71 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90532941 |
| 72 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.90321009 |
| 73 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.88980641 |
| 74 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87937255 |
| 75 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.86955213 |
| 76 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.86196723 |
| 77 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85968415 |
| 78 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.85236154 |
| 79 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.84387451 |
| 80 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.83581206 |
| 81 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83489467 |
| 82 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.83165725 |
| 83 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.80839684 |
| 84 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.80815385 |
| 85 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.80142736 |
| 86 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.80087220 |
| 87 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80013111 |
| 88 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.79369151 |
| 89 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.79338268 |
| 90 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.78693297 |
| 91 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77938757 |
| 92 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75759756 |
| 93 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.75586691 |
| 94 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74363225 |
| 95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.71146769 |
| 96 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70842826 |
| 97 | CBP_21632823_ChIP-Seq_H3396_Human | 0.70765438 |
| 98 | CJUN_26792858_Chip-Seq_BT549_Human | 0.70342188 |
| 99 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.70336638 |
| 100 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.68847739 |
| 101 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.68782782 |
| 102 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.67906199 |
| 103 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.67444734 |
| 104 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.67068839 |
| 105 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.66233035 |
| 106 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.65809067 |
| 107 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.65184211 |
| 108 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.64732890 |
| 109 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.64659007 |
| 110 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.64411921 |
| 111 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.63647332 |
| 112 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.63544607 |
| 113 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.62356611 |
| 114 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.61564550 |
| 115 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.60993539 |
| 116 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.60892882 |
| 117 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60638764 |
| 118 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.59903436 |
| 119 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.59513329 |
| 120 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.58142832 |
| 121 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.56452004 |
| 122 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.56408394 |
| 123 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.55410293 |
| 124 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.55291414 |
| 125 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.53939305 |
| 126 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52175360 |
| 127 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.51851702 |
| 128 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.50820568 |
| 129 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.50524195 |
| 130 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.50454116 |
| 131 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.48899722 |
| 132 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.48445511 |
| 133 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47060020 |
| 134 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.46843168 |
| 135 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.46601746 |
| 136 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.45670589 |
| 137 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45474873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.54892655 |
| 2 | MP0005360_urolithiasis | 5.00531040 |
| 3 | MP0005365_abnormal_bile_salt | 4.43188075 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.41475879 |
| 5 | MP0002837_dystrophic_cardiac_calcinosis | 3.74636523 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.44153478 |
| 7 | MP0004145_abnormal_muscle_electrophysio | 3.24906372 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.13148546 |
| 9 | MP0003646_muscle_fatigue | 3.13110739 |
| 10 | MP0004130_abnormal_muscle_cell | 3.04895167 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.92751960 |
| 12 | MP0005670_abnormal_white_adipose | 2.84825220 |
| 13 | MP0003252_abnormal_bile_duct | 2.56871627 |
| 14 | MP0005332_abnormal_amino_acid | 2.52560746 |
| 15 | MP0005666_abnormal_adipose_tissue | 2.38464149 |
| 16 | MP0004084_abnormal_cardiac_muscle | 2.33120316 |
| 17 | MP0009840_abnormal_foam_cell | 2.31515445 |
| 18 | MP0004215_abnormal_myocardial_fiber | 2.28507978 |
| 19 | MP0003195_calcinosis | 2.15361320 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 2.13035974 |
| 21 | MP0005330_cardiomyopathy | 2.11246100 |
| 22 | MP0006036_abnormal_mitochondrial_physio | 2.06653315 |
| 23 | MP0000751_myopathy | 2.00576213 |
| 24 | MP0004036_abnormal_muscle_relaxation | 2.00340839 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.89559004 |
| 26 | MP0005083_abnormal_biliary_tract | 1.83937875 |
| 27 | MP0005451_abnormal_body_composition | 1.80604033 |
| 28 | MP0000609_abnormal_liver_physiology | 1.76752550 |
| 29 | MP0002971_abnormal_brown_adipose | 1.75592755 |
| 30 | MP0004185_abnormal_adipocyte_glucose | 1.74022108 |
| 31 | MP0000749_muscle_degeneration | 1.71621391 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.65486940 |
| 33 | MP0001666_abnormal_nutrient_absorption | 1.61882550 |
| 34 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.61828074 |
| 35 | MP0004087_abnormal_muscle_fiber | 1.54860270 |
| 36 | MP0002972_abnormal_cardiac_muscle | 1.53988270 |
| 37 | MP0008775_abnormal_heart_ventricle | 1.53610103 |
| 38 | MP0005375_adipose_tissue_phenotype | 1.46144864 |
| 39 | MP0005385_cardiovascular_system_phenoty | 1.44225315 |
| 40 | MP0001544_abnormal_cardiovascular_syste | 1.44225315 |
| 41 | MP0005620_abnormal_muscle_contractility | 1.38342329 |
| 42 | MP0006138_congestive_heart_failure | 1.33641545 |
| 43 | MP0003186_abnormal_redox_activity | 1.30975303 |
| 44 | MP0009643_abnormal_urine_homeostasis | 1.28609632 |
| 45 | MP0005535_abnormal_body_temperature | 1.25735781 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 1.22709996 |
| 47 | MP0004510_myositis | 1.22656818 |
| 48 | MP0004272_abnormal_basement_membrane | 1.21515325 |
| 49 | MP0010630_abnormal_cardiac_muscle | 1.20672870 |
| 50 | MP0004019_abnormal_vitamin_homeostasis | 1.19372404 |
| 51 | MP0003137_abnormal_impulse_conducting | 1.19107777 |
| 52 | MP0002269_muscular_atrophy | 1.17811762 |
| 53 | MP0003656_abnormal_erythrocyte_physiolo | 1.14536319 |
| 54 | MP0005408_hypopigmentation | 1.12631814 |
| 55 | MP0003011_delayed_dark_adaptation | 1.11651568 |
| 56 | MP0005334_abnormal_fat_pad | 1.11313125 |
| 57 | MP0001764_abnormal_homeostasis | 1.10063679 |
| 58 | MP0002078_abnormal_glucose_homeostasis | 1.06960895 |
| 59 | MP0000750_abnormal_muscle_regeneration | 1.06726623 |
| 60 | MP0003221_abnormal_cardiomyocyte_apopto | 1.06363306 |
| 61 | MP0002108_abnormal_muscle_morphology | 1.06242440 |
| 62 | MP0010234_abnormal_vibrissa_follicle | 1.04755492 |
| 63 | MP0004043_abnormal_pH_regulation | 1.04172413 |
| 64 | MP0003690_abnormal_glial_cell | 1.03656389 |
| 65 | MP0006035_abnormal_mitochondrial_morpho | 1.01673831 |
| 66 | MP0002877_abnormal_melanocyte_morpholog | 1.00927360 |
| 67 | MP0004484_altered_response_of | 0.99714883 |
| 68 | MP0000747_muscle_weakness | 0.99238409 |
| 69 | MP0000733_abnormal_muscle_development | 0.98523167 |
| 70 | MP0002332_abnormal_exercise_endurance | 0.96284329 |
| 71 | MP0002106_abnormal_muscle_physiology | 0.95400663 |
| 72 | MP0002796_impaired_skin_barrier | 0.94924979 |
| 73 | MP0005647_abnormal_sex_gland | 0.93975931 |
| 74 | MP0005248_abnormal_Harderian_gland | 0.93626142 |
| 75 | MP0004085_abnormal_heartbeat | 0.92347228 |
| 76 | MP0005266_abnormal_metabolism | 0.91712784 |
| 77 | MP0004147_increased_porphyrin_level | 0.88702694 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 0.87871695 |
| 79 | MP0003941_abnormal_skin_development | 0.87025316 |
| 80 | MP0000230_abnormal_systemic_arterial | 0.86784536 |
| 81 | MP0009115_abnormal_fat_cell | 0.86079229 |
| 82 | MP0001661_extended_life_span | 0.84160840 |
| 83 | MP0008438_abnormal_cutaneous_collagen | 0.83879772 |
| 84 | MP0003329_amyloid_beta_deposits | 0.82635038 |
| 85 | MP0000759_abnormal_skeletal_muscle | 0.82419682 |
| 86 | MP0000604_amyloidosis | 0.81840848 |
| 87 | MP0003705_abnormal_hypodermis_morpholog | 0.81800461 |
| 88 | MP0003566_abnormal_cell_adhesion | 0.80480080 |
| 89 | MP0002970_abnormal_white_adipose | 0.79834026 |
| 90 | MP0010352_gastrointestinal_tract_polyps | 0.79830932 |
| 91 | MP0000013_abnormal_adipose_tissue | 0.78882691 |
| 92 | MP0009697_abnormal_copulation | 0.78332808 |
| 93 | MP0005636_abnormal_mineral_homeostasis | 0.77891227 |
| 94 | MP0003868_abnormal_feces_composition | 0.77006150 |
| 95 | MP0009764_decreased_sensitivity_to | 0.76233869 |
| 96 | MP0009763_increased_sensitivity_to | 0.75216047 |
| 97 | MP0000343_altered_response_to | 0.74890287 |
| 98 | MP0000598_abnormal_liver_morphology | 0.74318496 |
| 99 | MP0005165_increased_susceptibility_to | 0.74242656 |
| 100 | MP0005369_muscle_phenotype | 0.73992345 |
| 101 | MP0000003_abnormal_adipose_tissue | 0.73516959 |
| 102 | MP0000266_abnormal_heart_morphology | 0.73080044 |
| 103 | MP0009642_abnormal_blood_homeostasis | 0.70475493 |
| 104 | MP0003828_pulmonary_edema | 0.70081881 |
| 105 | MP0005275_abnormal_skin_tensile | 0.69795741 |
| 106 | MP0002876_abnormal_thyroid_physiology | 0.69674363 |
| 107 | MP0009384_cardiac_valve_regurgitation | 0.69510844 |
| 108 | MP0005448_abnormal_energy_balance | 0.68828023 |
| 109 | MP0001756_abnormal_urination | 0.68804463 |
| 110 | MP0010368_abnormal_lymphatic_system | 0.68329779 |
| 111 | MP0001853_heart_inflammation | 0.68209070 |
| 112 | MP0005376_homeostasis/metabolism_phenot | 0.68073532 |
| 113 | MP0002254_reproductive_system_inflammat | 0.66657268 |
| 114 | MP0003950_abnormal_plasma_membrane | 0.66483268 |
| 115 | MP0002132_abnormal_respiratory_system | 0.64596609 |
| 116 | MP0002128_abnormal_blood_circulation | 0.64502634 |
| 117 | MP0001958_emphysema | 0.60907897 |
| 118 | MP0004233_abnormal_muscle_weight | 0.60044519 |
| 119 | MP0002896_abnormal_bone_mineralization | 0.59505693 |
| 120 | MP0002127_abnormal_cardiovascular_syste | 0.58931838 |
| 121 | MP0005409_darkened_coat_color | 0.57510116 |
| 122 | MP0005058_abnormal_lysosome_morphology | 0.56841284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 6.91933299 |
| 2 | Nemaline bodies (HP:0003798) | 6.91320741 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.75563070 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 5.24797752 |
| 5 | Hypoglycemic coma (HP:0001325) | 4.99056670 |
| 6 | Abnormality of fatty-acid metabolism (HP:0004359) | 4.76145997 |
| 7 | Hyperammonemia (HP:0001987) | 4.69862347 |
| 8 | Hyperglycinuria (HP:0003108) | 4.60911331 |
| 9 | Myoglobinuria (HP:0002913) | 4.48689643 |
| 10 | EMG: myopathic abnormalities (HP:0003458) | 4.46111071 |
| 11 | Xanthomatosis (HP:0000991) | 4.44271799 |
| 12 | Ketosis (HP:0001946) | 4.40854586 |
| 13 | Intrahepatic cholestasis (HP:0001406) | 4.36932097 |
| 14 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.29222345 |
| 15 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.27458649 |
| 16 | Abnormality of glycine metabolism (HP:0010895) | 4.27458649 |
| 17 | Deep venous thrombosis (HP:0002625) | 4.22752593 |
| 18 | Ketoacidosis (HP:0001993) | 4.19088683 |
| 19 | Abnormality of the calf musculature (HP:0001430) | 4.08009588 |
| 20 | Hyperlipoproteinemia (HP:0010980) | 4.06372718 |
| 21 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 4.04466068 |
| 22 | Dicarboxylic aciduria (HP:0003215) | 4.04466068 |
| 23 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.95991075 |
| 24 | Bundle branch block (HP:0011710) | 3.89675917 |
| 25 | Hyperglycinemia (HP:0002154) | 3.73220865 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.70954842 |
| 27 | Neck muscle weakness (HP:0000467) | 3.70330729 |
| 28 | Rhabdomyolysis (HP:0003201) | 3.62490219 |
| 29 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.57381413 |
| 30 | Subaortic stenosis (HP:0001682) | 3.54678325 |
| 31 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.54678325 |
| 32 | Sudden death (HP:0001699) | 3.52038683 |
| 33 | Exercise-induced myalgia (HP:0003738) | 3.49179006 |
| 34 | Epidermoid cyst (HP:0200040) | 3.44873489 |
| 35 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.43451851 |
| 36 | Increased connective tissue (HP:0009025) | 3.41863478 |
| 37 | Hypobetalipoproteinemia (HP:0003563) | 3.40651222 |
| 38 | Hypolipoproteinemia (HP:0010981) | 3.39822756 |
| 39 | Generalized aminoaciduria (HP:0002909) | 3.38208106 |
| 40 | Prolonged partial thromboplastin time (HP:0003645) | 3.33006683 |
| 41 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.31802515 |
| 42 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.27459994 |
| 43 | Ventricular tachycardia (HP:0004756) | 3.27257348 |
| 44 | Distal arthrogryposis (HP:0005684) | 3.25103256 |
| 45 | Complement deficiency (HP:0004431) | 3.21324285 |
| 46 | Hepatic necrosis (HP:0002605) | 3.19486544 |
| 47 | Rimmed vacuoles (HP:0003805) | 3.19322906 |
| 48 | Distal lower limb muscle weakness (HP:0009053) | 3.18079162 |
| 49 | Cerebral edema (HP:0002181) | 3.17705383 |
| 50 | Increased variability in muscle fiber diameter (HP:0003557) | 3.13531779 |
| 51 | Right ventricular cardiomyopathy (HP:0011663) | 3.08478065 |
| 52 | Metabolic acidosis (HP:0001942) | 2.95086474 |
| 53 | Exercise-induced muscle cramps (HP:0003710) | 2.94183294 |
| 54 | Lethargy (HP:0001254) | 2.93158821 |
| 55 | Myopathic facies (HP:0002058) | 2.92551339 |
| 56 | Hyporeflexia of lower limbs (HP:0002600) | 2.89350472 |
| 57 | Palpitations (HP:0001962) | 2.84629467 |
| 58 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.83745280 |
| 59 | Abnormality of serum amino acid levels (HP:0003112) | 2.80961826 |
| 60 | Increased muscle lipid content (HP:0009058) | 2.78693323 |
| 61 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.78010679 |
| 62 | Ulnar deviation of the wrist (HP:0003049) | 2.74304743 |
| 63 | Proximal tubulopathy (HP:0000114) | 2.68808703 |
| 64 | Calf muscle hypertrophy (HP:0008981) | 2.68335657 |
| 65 | Lipoatrophy (HP:0100578) | 2.61507173 |
| 66 | Round ear (HP:0100830) | 2.61007911 |
| 67 | Frequent falls (HP:0002359) | 2.58393734 |
| 68 | Acute encephalopathy (HP:0006846) | 2.54067508 |
| 69 | Nausea (HP:0002018) | 2.51361777 |
| 70 | Hypercholesterolemia (HP:0003124) | 2.50197423 |
| 71 | Abnormality of methionine metabolism (HP:0010901) | 2.49089656 |
| 72 | Skin nodule (HP:0200036) | 2.48430878 |
| 73 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.48257249 |
| 74 | Atrial fibrillation (HP:0005110) | 2.45826973 |
| 75 | Atrioventricular block (HP:0001678) | 2.45104166 |
| 76 | Vomiting (HP:0002013) | 2.44838547 |
| 77 | Renal cortical cysts (HP:0000803) | 2.43643865 |
| 78 | Muscle fiber splitting (HP:0003555) | 2.41172889 |
| 79 | Dilated cardiomyopathy (HP:0001644) | 2.40910879 |
| 80 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.40292530 |
| 81 | Areflexia of lower limbs (HP:0002522) | 2.40112930 |
| 82 | Syncope (HP:0001279) | 2.39424738 |
| 83 | Abnormality of the common coagulation pathway (HP:0010990) | 2.34838030 |
| 84 | EMG: neuropathic changes (HP:0003445) | 2.31369426 |
| 85 | Abnormality of purine metabolism (HP:0004352) | 2.30868643 |
| 86 | Abnormality of glycolysis (HP:0004366) | 2.30714819 |
| 87 | Increased serum pyruvate (HP:0003542) | 2.30714819 |
| 88 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.26260067 |
| 89 | Hyperbilirubinemia (HP:0002904) | 2.25324139 |
| 90 | Primary atrial arrhythmia (HP:0001692) | 2.23739474 |
| 91 | Fat malabsorption (HP:0002630) | 2.22924091 |
| 92 | Hepatocellular necrosis (HP:0001404) | 2.22683543 |
| 93 | Calcaneovalgus deformity (HP:0001848) | 2.22457198 |
| 94 | Cholelithiasis (HP:0001081) | 2.22042535 |
| 95 | Abnormal gallbladder morphology (HP:0012437) | 2.21702224 |
| 96 | Lactic acidosis (HP:0003128) | 2.19747475 |
| 97 | Abnormality of complement system (HP:0005339) | 2.19093224 |
| 98 | Absent phalangeal crease (HP:0006109) | 2.16719492 |
| 99 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.16443444 |
| 100 | Muscle stiffness (HP:0003552) | 2.15910018 |
| 101 | Methylmalonic aciduria (HP:0012120) | 2.15098290 |
| 102 | Generalized muscle weakness (HP:0003324) | 2.14955220 |
| 103 | Heart block (HP:0012722) | 2.14486260 |
| 104 | Joint hemorrhage (HP:0005261) | 2.14374598 |
| 105 | Asymmetric septal hypertrophy (HP:0001670) | 2.14313737 |
| 106 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.13621828 |
| 107 | Supraventricular tachycardia (HP:0004755) | 2.13496682 |
| 108 | Gowers sign (HP:0003391) | 2.12843371 |
| 109 | Hypertriglyceridemia (HP:0002155) | 2.11628001 |
| 110 | Hypoglycemic seizures (HP:0002173) | 2.11351166 |
| 111 | Abnormality of the foot musculature (HP:0001436) | 2.09810769 |
| 112 | Supraventricular arrhythmia (HP:0005115) | 2.09044944 |
| 113 | Delayed CNS myelination (HP:0002188) | 2.08533791 |
| 114 | Abnormality of urine glucose concentration (HP:0011016) | 2.07849099 |
| 115 | Glycosuria (HP:0003076) | 2.07849099 |
| 116 | Conjunctival hamartoma (HP:0100780) | 2.07596549 |
| 117 | Scapular winging (HP:0003691) | 2.04888649 |
| 118 | Abnormality of the intrinsic pathway (HP:0010989) | 2.04290464 |
| 119 | Late onset (HP:0003584) | 2.04165465 |
| 120 | Difficulty running (HP:0009046) | 2.03778621 |
| 121 | Gout (HP:0001997) | 2.01727664 |
| 122 | Abnormal atrioventricular conduction (HP:0005150) | 2.00587542 |
| 123 | Abnormality of alanine metabolism (HP:0010916) | 2.00555524 |
| 124 | Hyperalaninemia (HP:0003348) | 2.00555524 |
| 125 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.00555524 |
| 126 | Mitral stenosis (HP:0001718) | 2.00536388 |
| 127 | Hyperglycemia (HP:0003074) | 2.00380734 |
| 128 | Ventricular arrhythmia (HP:0004308) | 2.00098226 |
| 129 | Oligomenorrhea (HP:0000876) | 1.98800809 |
| 130 | Distal lower limb amyotrophy (HP:0008944) | 1.98663746 |
| 131 | Myotonia (HP:0002486) | 1.98233205 |
| 132 | Ragged-red muscle fibers (HP:0003200) | 1.97577056 |
| 133 | Acute necrotizing encephalopathy (HP:0006965) | 1.96936955 |
| 134 | Foot dorsiflexor weakness (HP:0009027) | 1.94873183 |
| 135 | Limb-girdle muscle atrophy (HP:0003797) | 1.92898468 |
| 136 | Reduced antithrombin III activity (HP:0001976) | 1.91512110 |
| 137 | Progressive muscle weakness (HP:0003323) | 1.88468179 |
| 138 | Abnormal finger flexion creases (HP:0006143) | 1.85978329 |
| 139 | Deformed tarsal bones (HP:0008119) | 1.84922758 |
| 140 | Spinal rigidity (HP:0003306) | 1.84027177 |
| 141 | Malignant hyperthermia (HP:0002047) | 1.83717131 |
| 142 | Pheochromocytoma (HP:0002666) | 1.80784671 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.54626938 |
| 2 | PDK4 | 4.53043806 |
| 3 | PDK3 | 4.53043806 |
| 4 | TRIB3 | 3.48475532 |
| 5 | LMTK2 | 2.85889436 |
| 6 | PDK2 | 2.74253789 |
| 7 | TTN | 2.62548770 |
| 8 | SIK1 | 2.45466618 |
| 9 | OBSCN | 2.38988227 |
| 10 | STK24 | 2.30450783 |
| 11 | PKN2 | 2.25667714 |
| 12 | PHKG2 | 2.24137845 |
| 13 | PHKG1 | 2.24137845 |
| 14 | EIF2AK1 | 2.16691783 |
| 15 | INSRR | 2.15408137 |
| 16 | MYLK | 2.10608163 |
| 17 | PBK | 2.06819069 |
| 18 | ERN1 | 1.87676154 |
| 19 | FGFR4 | 1.87092956 |
| 20 | PINK1 | 1.79940987 |
| 21 | SCYL2 | 1.78894046 |
| 22 | STK39 | 1.59196418 |
| 23 | WNK4 | 1.51043028 |
| 24 | EPHB1 | 1.49798903 |
| 25 | PRKAA2 | 1.48777211 |
| 26 | CAMK1D | 1.46915047 |
| 27 | PIK3CA | 1.39242224 |
| 28 | NEK9 | 1.27639143 |
| 29 | TIE1 | 1.26997325 |
| 30 | MUSK | 1.24201590 |
| 31 | ERBB3 | 1.19275146 |
| 32 | PIK3CG | 1.17779866 |
| 33 | MST1R | 1.16666233 |
| 34 | MAPKAPK3 | 1.08659611 |
| 35 | FLT3 | 1.08508577 |
| 36 | NEK1 | 1.04723933 |
| 37 | RAF1 | 1.04603065 |
| 38 | EIF2AK3 | 1.03030803 |
| 39 | LATS2 | 1.02861371 |
| 40 | EEF2K | 1.01091353 |
| 41 | LIMK1 | 1.00169466 |
| 42 | PDGFRA | 0.98494310 |
| 43 | CCNB1 | 0.97762756 |
| 44 | BRSK2 | 0.96785527 |
| 45 | PRKAA1 | 0.95117776 |
| 46 | DMPK | 0.92131165 |
| 47 | MOS | 0.92098015 |
| 48 | MAP3K12 | 0.89867544 |
| 49 | PDPK1 | 0.89649491 |
| 50 | MAP3K7 | 0.89644770 |
| 51 | FGFR2 | 0.89012910 |
| 52 | MAP3K2 | 0.87988411 |
| 53 | PTK6 | 0.87951353 |
| 54 | ERBB4 | 0.87762023 |
| 55 | STK38L | 0.87354037 |
| 56 | PRKD1 | 0.85135618 |
| 57 | YES1 | 0.84526873 |
| 58 | AKT2 | 0.83100679 |
| 59 | LATS1 | 0.81570737 |
| 60 | MAPK11 | 0.80919976 |
| 61 | MST4 | 0.77768099 |
| 62 | JAK2 | 0.76218122 |
| 63 | PDK1 | 0.76094919 |
| 64 | MAP2K4 | 0.74731262 |
| 65 | CAMK1G | 0.73561123 |
| 66 | MAPK12 | 0.73551572 |
| 67 | GRK7 | 0.72996276 |
| 68 | PAK3 | 0.72864465 |
| 69 | PRKACG | 0.72380670 |
| 70 | CAMK2D | 0.71398668 |
| 71 | MAP3K3 | 0.70317450 |
| 72 | TTK | 0.70275859 |
| 73 | KDR | 0.69434054 |
| 74 | JAK1 | 0.68914602 |
| 75 | TAOK3 | 0.68515948 |
| 76 | RIPK1 | 0.67893591 |
| 77 | ROCK2 | 0.67442236 |
| 78 | TYK2 | 0.64544271 |
| 79 | WNK1 | 0.62019615 |
| 80 | ARAF | 0.61282536 |
| 81 | AKT3 | 0.59785666 |
| 82 | EPHA3 | 0.58349332 |
| 83 | CAMK2G | 0.56603564 |
| 84 | ILK | 0.56602845 |
| 85 | ABL2 | 0.55973377 |
| 86 | PAK4 | 0.55947231 |
| 87 | SGK3 | 0.54106566 |
| 88 | STK4 | 0.53909000 |
| 89 | OXSR1 | 0.53026377 |
| 90 | RET | 0.52770218 |
| 91 | WEE1 | 0.52638811 |
| 92 | RPS6KB2 | 0.51562093 |
| 93 | MAP2K3 | 0.51317254 |
| 94 | TGFBR2 | 0.50008950 |
| 95 | MET | 0.49873684 |
| 96 | MAP3K6 | 0.49588963 |
| 97 | PKN1 | 0.47928235 |
| 98 | FRK | 0.47754853 |
| 99 | PLK4 | 0.47302837 |
| 100 | MAP2K1 | 0.46785200 |
| 101 | SGK223 | 0.46493531 |
| 102 | SGK494 | 0.46493531 |
| 103 | LRRK2 | 0.46279255 |
| 104 | PTK2 | 0.46132496 |
| 105 | PRKCH | 0.45281583 |
| 106 | FGFR3 | 0.44865675 |
| 107 | TBK1 | 0.43510343 |
| 108 | TRPM7 | 0.43268532 |
| 109 | MAPK4 | 0.43253259 |
| 110 | MAPK7 | 0.41200151 |
| 111 | PRKG1 | 0.41128182 |
| 112 | MAP3K5 | 0.40885787 |
| 113 | PRKCQ | 0.40737139 |
| 114 | KSR2 | 0.40318894 |
| 115 | ROCK1 | 0.38967907 |
| 116 | PRKG2 | 0.38886419 |
| 117 | GSK3A | 0.38485726 |
| 118 | PRKACA | 0.38417966 |
| 119 | STK38 | 0.36161285 |
| 120 | SGK2 | 0.34932557 |
| 121 | MAPKAPK5 | 0.33353760 |
| 122 | FER | 0.32792302 |
| 123 | TESK1 | 0.32475332 |
| 124 | PRKACB | 0.31310630 |
| 125 | EIF2AK2 | 0.31269573 |
| 126 | ICK | 0.31042654 |
| 127 | STK3 | 0.30346193 |
| 128 | BRAF | 0.30100606 |
| 129 | MAP3K8 | 0.29452597 |
| 130 | CAMK1 | 0.29060877 |
| 131 | CDK6 | 0.28248032 |
| 132 | FGFR1 | 0.27277749 |
| 133 | IRAK1 | 0.27172343 |
| 134 | CAMK4 | 0.27079612 |
| 135 | IGF1R | 0.27039361 |
| 136 | MAP3K13 | 0.26199593 |
| 137 | PRKCE | 0.24892265 |
| 138 | CAMK2A | 0.24546760 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid degradation_Homo sapiens_hsa00071 | 3.61747781 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.59015469 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.33642135 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.10717583 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 3.04391582 |
| 6 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.94245178 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.80240836 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.74405009 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.71877183 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.66522628 |
| 11 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.66315979 |
| 12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.47673104 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.46421748 |
| 14 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.29247304 |
| 15 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.27081608 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.19939175 |
| 17 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.18318815 |
| 18 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.14240235 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 2.04371573 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.97921565 |
| 21 | Carbon metabolism_Homo sapiens_hsa01200 | 1.97028269 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.89259864 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.79479956 |
| 24 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.60842055 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.58027012 |
| 26 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.57092949 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.56627440 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38820955 |
| 29 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.38740629 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.34379557 |
| 31 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.33646732 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.27313348 |
| 33 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26017638 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.25077086 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.20854759 |
| 36 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18319051 |
| 37 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.15450795 |
| 38 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.12204253 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.11887941 |
| 40 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.10333407 |
| 41 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.09521258 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.07511492 |
| 43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.07345708 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.05971337 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.05320800 |
| 46 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.03514407 |
| 47 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00519563 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 0.89666333 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.87285042 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.87118485 |
| 51 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.86707486 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86677160 |
| 53 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.84910238 |
| 54 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.81829961 |
| 55 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.81694632 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.81450444 |
| 57 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.81019300 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78672893 |
| 59 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.78094677 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.74380048 |
| 61 | Parkinsons disease_Homo sapiens_hsa05012 | 0.73768406 |
| 62 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.73058207 |
| 63 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.71148390 |
| 64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69780292 |
| 65 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.64870006 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64779484 |
| 67 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.63129972 |
| 68 | Insulin resistance_Homo sapiens_hsa04931 | 0.61990604 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52314461 |
| 70 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51617270 |
| 71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51088786 |
| 72 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49237803 |
| 73 | Alzheimers disease_Homo sapiens_hsa05010 | 0.49138817 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.46690189 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45874030 |
| 76 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.41482607 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40877333 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.40496575 |
| 79 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39339246 |
| 80 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.34357009 |
| 81 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.34277058 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.33564732 |
| 83 | Adherens junction_Homo sapiens_hsa04520 | 0.31227314 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.31045522 |
| 85 | Focal adhesion_Homo sapiens_hsa04510 | 0.30418637 |
| 86 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30302965 |
| 87 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29666693 |
| 88 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27818744 |
| 89 | Huntingtons disease_Homo sapiens_hsa05016 | 0.27818714 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | 0.27321403 |
| 91 | Tight junction_Homo sapiens_hsa04530 | 0.24898275 |
| 92 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.24882554 |
| 93 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.22317660 |
| 94 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.20156466 |
| 95 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.13367622 |
| 96 | Thyroid cancer_Homo sapiens_hsa05216 | 0.13311784 |
| 97 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.12343251 |
| 98 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.12188453 |
| 99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.11202825 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.10610773 |
| 101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.09192992 |
| 102 | Renin secretion_Homo sapiens_hsa04924 | 0.07444850 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.04995118 |
| 104 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.03922087 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.01864041 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.01603851 |
| 107 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.01414131 |
| 108 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.1343742 |
| 109 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | -0.1260638 |
| 110 | Viral myocarditis_Homo sapiens_hsa05416 | -0.1234459 |
| 111 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1204760 |
| 112 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1001420 |
| 113 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | -0.0325651 |

